Clinical trial
Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome…
NCT00171548 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171548 |
|---|---|
| Title | Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients |
| Official title | Project to Promote the Evaluation of Cardiovascular Risk in Clinical Practice, and Assess Its Evolution After the Implementation of Multifactorial Preventive Strategy Aimed at Reducing the Level of Global Risk (SCORE Algorithm) in Subjects With Metabolic Syndrome and a Risk Level of 5% |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Metabolic Syndrome |
| Enrollment | 600 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 22, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: